ADPT Adaptive Biotech Net earnings per share growth forecast for next year
Adaptive Biotechnologies leads the field of immunomics by applying AI to DNA analysis. The use of machine learning to decode the immune response enables the creation of ultra-precise diagnostics, which is supported by the projected EPS growth for the coming year. Tests for personalized medicine are being actively developed. Meanwhile, 82.70 is the current metric reflecting the latest Wall Street profit forecasts.
Analytical breakdowns for adaptivebiotech.com (ADPT)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Total Debt to Capital Adaptive Biotechnologies|ADPT - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Adaptive Biotechnologies Corporation|ADPT - Company Aggregate Debts|Debt to Book Capitalization Ratio Adaptive Biotechnologies|ADPT - Long-Term Liabilities|Company Current Liabilities Adaptive Biotechnologies|Quick Ratio adaptivebiotech.com
- earnings and valuation multiples information:
ADPT - Net Financial Result|Future Profit Adaptive Biotechnologies|ADPT - Price to Earnings Ratio|Forward P/E Multiple Adaptive Biotechnologies|ADPT - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Adaptive Biotechnologies|ADPT - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Adaptive Biotechnologies|ADPT - Earnings per share for the last twelve months|Quarterly EPS earnings growth adaptivebiotech.com|ADPT - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Adaptive Biotechnologies
Basic company analysis:ADPT, Adaptive Biotechnologies Corp
Investors assess capital risks through future return dynamics, weighing profit growth rates against inflationary pressure on costs. For Adaptive Biotechnologies (ADPT), the valuation of expected EPS growth for the coming year reflects the dependency of profits on the adoption of reimbursement systems by US insurance companies, allowing for the determination of the business's margin of safety amid limited pricing power during the commercialization phase.
Who Adaptive Biotechnologies competes with
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|Kiniksa Pharmaceuticals Ltd - Earnings growth forecast for next year|GRFS - Earnings growth forecast for next year|CLDX: Earnings growth forecast for next year|Projected earnings per share growth rate for next year AUPH|BCRX (BioCryst Pharmaceuticals) - Earnings growth forecast for next year|Earnings growth forecast for next year Vera Therapeutics Inc|Net earnings per share growth forecast for next year Dianthus Pharma (DNTH)|PHVS: Net earnings per share change forecast for next year|AbCellera Biologics - Expected earnings per share growth for next year|Projected earnings per share increase next year TRML (tourmalinebio.com)|Precigen - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Pharming Group NV PHAR|NKTR (Nektar) - Expected earnings per share growth for next year|UPB (Upstream Pharma) - Net earnings per share growth forecast for next year|ZBIO (Zenas Biopharma Inc) - Earnings growth forecast for next year|Expected net earnings per share growth next year immunome.com IMNM|Expected earnings per share growth for next year GOSS (Gossamer Bio)|KALV (KalVista Pharma) - Expected earnings per share trend next year|Earnings growth forecast for next year SEPN (Septerna Corp)|Pieris Corp - Net earnings per share growth forecast for next year|Savara Inc. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year rigel.com RIGL|AnaptysBio (ANAB) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Astria Therapeutics Inc (ATXS)|Expected earnings per share growth for next year ENGN|RAPT (RAPT Therapeutics Inc.) - Projected earnings per share increase next year|Earnings growth forecast for next year JBIO|ACRS - Expected net earnings per share growth next year|Earnings growth forecast for next year KYTX (Kyverna Therapeutics, Inc.)|TLSA - Expected earnings per share growth for next year|Cabaletta Bio, Inc - Earnings growth forecast for next year|Expected earnings per share trend next year VTYX (Ventyx Biosciences, Inc)|Theratechnologies Inc. (THTX) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year AVTX|Net earnings per share growth forecast for next year Eledon Pharmaceuticals, Inc.|Expected net earnings per share growth next year Agenus, Inc. AGEN|Net earnings per share growth forecast for next year Climb Bio, Inc. (CLYM)|Net earnings per share growth forecast for next year ZURA (Zura Bio Ltd)|Net earnings per share growth forecast for next year aTyr Pharma, Inc. ATYR|Adagene Inc (ADAG) - Expected net earnings per share growth next year|Ikena Oncology, Inc. - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Shattuck Labs, Inc. (STTK)|EQ: Earnings growth forecast for next year|CNTB - Consensus forecast of earnings per share growth for next year|IMUX (Immunic Therapeutics) - Earnings growth forecast for next year|Expected net earnings per share growth next year Atara Biotherapeutics Inc ATRA|Net earnings per share growth forecast for next year InflaRx N.V. (IFRX)|Consensus forecast of earnings per share growth for next year X4 Pharmaceuticals Inc.|Earnings growth forecast for next year ACET (Adicet Bio, Inc.)|Earnings growth forecast for next year Celularity Inc CELU|INmune Bio, Inc. - Earnings growth forecast for next year|BRNS (barinthusbio.com) - Projected earnings per share growth rate for next year|Kezar Life Sciences, Inc. (KZR) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year SABS (SAB Biotherapeutics Inc.)|Expected earnings per share growth for next year AKTX|ENLV (Enlivex Therapeutics, Ltd.) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year Q32 Bio Inc. (QTTB)|GOVX: Net earnings per share change forecast for next year|Earnings growth forecast for next year EDSA (Edesa Biotech)|Expected earnings per share trend next year IBIO|Carisma Tx - Earnings growth forecast for next year|XTLB - Earnings growth forecast for next year|boltbio.com (BOLT) - Net earnings per share growth forecast for next year|HCW Biologics - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Aptevo Therapeutics, Inc.|Expected earnings per share growth for next year AIM ImmunoTech, Inc. (AIM)|Earnings growth forecast for next year ADTX|Earnings growth forecast for next year GRI Bio Corporation (GRI)|XORTX Therapeutics Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year HIND|Revelation Biosciences, Inc. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Indaptus Therapeutics Inc INDP|Scinai (SCNI) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year CalciMedica|Net earnings per share growth forecast for next year Affimed NV|Expected earnings per share growth for next year Allakos Therapeutics (ALLK)|Expected earnings per share growth for next year HOOK (HOOKIPA Pharma Inc.)|Earnings growth forecast for next year igmbio.com (IGMS)|Net earnings per share growth forecast for next year iTeos ITOS|OCEA: Projected earnings per share growth rate for next year|TC Biopharm - Earnings growth forecast for next year|Expected net earnings per share growth next year thirdharmonicbio.com
